Sequencing and Genomic Technologies

Sequencing and Genomic Technologies

SERVICE UPDATE

September 24, 2021

The Genomic Analysis and Bioinformatics Core is currently closed and unable to take on any new work. GCB and B&B are working to assess the bioinformatics needs of the University, but this process will take time.

The High Throughput Sequencing services offered by the Sequencing and Genomic Technologies Core are not affected by the closure of the Bioinformatics core. The sequencing core will continue to provide all the sequencing services that you have been relying on for your research.   

The Sequencing and Genomic Technologies Core Facility will begin to provide some standard data processing services such as RNA-seq, WES and Methyl-seq. More details about those services, their schope and pricing will be forthcoming. 

June 15, 2021

The Sequencing and Genomic Technologies Core Facility has purchased an Oxford Nanopore GridION sequencer and will start offering Oxford Nanopore sequencing services in the coming months. 

January 8, 2021

The Sequencing and Genomic Technologies Core now offers single-cell multi-omics assays on the Tapestri Platform. This innovative platform analyzes genotype and phenotype simultaneously from the same single cells, which lets you reveal clonal heterogeneity and target comprehensive biomarkers.

tapestri platform for single cell multi omics assays

November 16, 2020

COVID-19: The COVID-19 pandemic is generating various supply chain issues for lab consumables, such as tips, 96-well plates and more recently, Illumina sequencing reagents (NovaSeq S-Prime flow cells, in particular). As a consequence, the turnaround time for some of our sequencing services may be impacted. We are doing our best to secure necessary supplies, and we thank you for your patience during these difficult times.

Reminder, the lab is located  at
Duke Center for Genomic and Computational Biology
Duke University
Chesterfield Bldg. 
701 W. Main Street
Suite 320
Durham NC 27701

Start DUGSIM

scientist in the lab

Next-Generation Sequencing Solutions
Illumina, Oxford Nanopore, Single Cell Targeted sequencing and Various NGS Library preparation

Email us          Consultation


The Sequencing and Genomic Technologies Shared Resource is a basic research oriented core facility affiliated with the Duke Cancer Institute (DCI). This Shared Resource has a track record more than a decade-long of providing constantly updated, state-of-the-art genomic services. The Sequencing and Genomic Technologies Shared Resource offers the full range of genomic technologies, making it much simpler for researchers to find the right service for their needs.

Interim Director Holly Dressman is available for project consultations. Contact her at holly.dressman@duke.edu.


PUBLICATION ACKNOWLEDGEMENT

For all publications that include data generated in the Sequencing and Genomic Technologies Shared Resource, we kindly request that you acknowledge this support:

We thank the Duke University School of Medicine for the use of the Sequencing and Genomic Technologies Shared Resource, which provided _________ service.


Average Time in Queue

Client-Submitted Libraries Core-Created Libraries
MiSeq 2 weeks 3-4 weeks
NextSeq 10 days 3-4 weeks
NovaSeq 6000 full flow cells 10 days 3-4 weeks
Novaseq 6000 by the lane Dependent on how quickly a flow cell can be filled Dependent on how quickly a flow cell can be filled

Announcements

June 15, 2021

The Sequencing and Genomic Technologies Core Facility has purchased an Oxford Nanopore GridION sequencer and will start offering Oxford Nanopore sequencing services in the coming months. 

January 8, 2021

The Sequencing and Genomic Technologies Core now offers single-cell multi-omics assays on the Tapestri Platform fo